(19)
(11) EP 1 177 016 A2

(12)

(88) Date of publication A3:
18.10.2001

(43) Date of publication:
06.02.2002 Bulletin 2002/06

(21) Application number: 00970426.3

(22) Date of filing: 01.03.2000
(51) International Patent Classification (IPC)7A61P 35/00, A61K 45/06, A61K 31/70
(86) International application number:
PCT/US0005/186
(87) International publication number:
WO 0078/299 (28.12.2000 Gazette 2000/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.03.1999 GB 9904932

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventor:
  • DAVIS, Stephen Thomas,Glaxo Wellcome Inc.
    Research Triangle Park, NC 27709 (US)

(74) Representative: Dolton, Peter Irving Ernest et al
GlaxoSmithKline Corporate Intellectual Property Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) COMPOSITION AND METHOD FOR PREVENTING/REDUCING THE SEVERITY OF SIDE EFFECTS OF CHEMOTHERAPY AND/OR RADIATION THERAPY